| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/BJO.76.6.332 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC504279 |
| https://europepmc.org/articles/PMC504279?pdf=render | ||
| https://syndication.highwire.org/content/doi/10.1136/bjo.76.6.332 | ||
| P932 | PMC publication ID | 504279 |
| P698 | PubMed publication ID | 1622942 |
| P5875 | ResearchGate publication ID | 21532675 |
| P2093 | author name string | H. Young | |
| MacKie R | |||
| J. L. Jay | |||
| A. I. Fern | |||
| R. MacKie | |||
| P2860 | cites work | Conjunctival involvement in cicatricial and bullous pemphigoid: a clinical and immunopathological study | Q33646909 |
| Glaucoma in patients with ocular cicatricial pemphigoid | Q38604026 | ||
| Localized chronic pemphigoid. Report of a case, review of the literature and discussion of the relationship with cicatricial pemphigoid | Q39712490 | ||
| The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis | Q40152599 | ||
| Bullous Pemphigoid Responding to Sulfapyridine and the Sulfones | Q40770653 | ||
| Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy | Q40795477 | ||
| Autoimmune Phenomena of the External Eye | Q40959623 | ||
| Enigma of ocular cicatricial pemphigoid. A comparative study of clinical and immunological findings | Q41195870 | ||
| Drug-induced cicatricial pemphigoid affecting the conjunctiva. Light and electron microscopic features | Q42521669 | ||
| Pemphigoid related to epinephrine treatment | Q45713516 | ||
| Dapsone as first line therapy for bullous pemphigoid. | Q54116075 | ||
| Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. | Q55062922 | ||
| The Acute Manifestations of Ocular Cicatricial Pemphigoid: Diagnosis and Treatment | Q66994631 | ||
| Inhibition of lysosomal enzymes by dapsone | Q67348761 | ||
| Induced ocular pseudopemphigoid | Q67487055 | ||
| Cicatricial pemphigoid | Q68158346 | ||
| Ocular cicatricial pemphigoid | Q70149761 | ||
| Immunosuppressive therapy for progressive ocular cicatricial pemphigoid | Q70249115 | ||
| Linear IgA disease in adults | Q70260736 | ||
| Immunosuppressive Therapy in Ocular Cicatricial Pemphigoid | Q70287560 | ||
| Benign mucous membrane pemphigoid | Q70601259 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dapsone | Q422226 |
| pemphigoid | Q881811 | ||
| ophthalmology | Q161437 | ||
| P304 | page(s) | 332-335 | |
| P577 | publication date | 1992-06-01 | |
| P1433 | published in | British Journal of Ophthalmology | Q13443571 |
| P1476 | title | Dapsone therapy for the acute inflammatory phase of ocular pemphigoid | |
| P478 | volume | 76 |
| Q34615160 | Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management |
| Q35164653 | Autoimmune bullous dermatoses in the elderly: diagnosis and management |
| Q36237529 | Autoimmune bullous diseases: ocular manifestations and management |
| Q40773560 | Chronic progressive conjunctival cicatrisation |
| Q45592824 | Cicatricial pemphigoid, mucous membrane pemphigoid |
| Q33853472 | Dapsone: unapproved uses or indications |
| Q24250186 | Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita |
| Q36168693 | Ocular cicatricial pemphigoid: manifestations and management |
| Q37264280 | Ocular mucous membrane pemphigoid: diagnosis and management strategies. |
| Q41444884 | Periodontal implications: mucocutaneous disorders |
| Q72801376 | The value of biopsies in the evaluation of chronic progressive conjunctival cicatrisation |
| Q35919150 | Therapy of autoimmune bullous diseases |
| Q38169809 | Urban legend series: mucous membrane pemphigoid |
Search more.